TPST - Tempest Therapeutics Inc
2.39
0.080 3.347%
Share volume: 71,599
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$2.31
0.08
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-27-2025 | 05-13-2025 | 08-11-2025 | 11-05-2025 | |
| Assets | ||||||||
| Total Assets | 44.378 M | 42.169 M | 33.836 M | 41.488 M | 32.164 M | 24.484 M | 17.129 M | |
| Current Assets | 33.497 M | 31.548 M | 23.552 M | 31.474 M | 22.433 M | 15.103 M | 8.104 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 32.326 M | 31.124 M | 22.116 M | 30.268 M | 21.511 M | 14.280 M | 7.514 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 920.000 K | 1.014 M | 932.000 K | 886.000 K | 817.000 K | 748.000 K | 681.000 K | |
| Other Assets | 9.961 M | 9.607 M | 9.352 M | 9.128 M | 8.914 M | 8.633 M | 8.344 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 44.378 M | 42.169 M | 33.836 M | 41.488 M | 32.164 M | 24.484 M | 17.129 M | |
| Total liabilities | 23.746 M | 25.230 M | 22.379 M | 22.362 M | 21.031 M | 14.701 M | 10.783 M | |
| Total current liabilities | 10.691 M | 14.559 M | 13.973 M | 14.220 M | 13.177 M | 7.141 M | 3.525 M | |
| Accounts Payable | 1.051 M | 1.357 M | 1.697 M | 2.450 M | 2.187 M | 4.716 M | 922.000 K | |
| Other liabilities | 8.915 M | 8.663 M | 8.406 M | 8.142 M | 7.854 M | 0.000 | 7.258 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 4.140 M | 2.008 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.915 M | 8.663 M | 8.406 M | 8.142 M | 7.854 M | 0.000 | 7.258 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 20.632 M | 16.939 M | 11.457 M | 19.126 M | 11.133 M | 9.783 M | 6.346 M | |
| Common stock | 193.799 M | 199.676 M | 204.750 M | 226.232 M | 229.099 M | 235.619 M | 235.693 M | |
| Retained earnings | -173.167 M | -182.737 M | -193.293 M | -207.106 M | -217.966 M | -225.836 M | -229.347 M |